Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

This study examines patient correlates of buprenorphine retention and whether an integrated, interdisciplinary treatment model (buprenorphine and behavioral health) is associated with higher odds of b
Original research | 2021
About prescribers, Outcomes, Substitution/OAT, Mental health
In Canada, restrictions on BUP-NX prescribing were relaxed in 2016, which may have had an effect on rates of diversion and non-prescribed use.
Original research | 2022
Hesitancy of prescribers , About PWUD, Substitution/OAT, Diversion
The current study examined how COVID-19 has impacted substance use supply and use characteristics among a national cohort of PWUD in Canada.
Original research | 2021
Overdose, Evidence base, Harm reduction, Policy/Regulatory, Safer supply, Advocacy, About PWUD
Our aim was to develop a filter that efficiently removes spore-forming bacteria and is also likely to be acceptable for use by people who inject drugs (i.e. quick, simple and not spoil the hit).
Original research | 2016
Harm reduction, Safer supply, About PWUD, Injecting drugs
Philadelphia launched a Police Assisted Diversion (PAD) program to address the highest rates of poverty, incarceration, and fatal overdose among large cities in the U.S.
Original research | 2022
Social services, Housing, Crime, Legal system/law enforcement, Illegal drugs

The key goal of this guide is to help harm reduction organizations and drug policy advocates hire and work with active drug users

Guidelines | 2010
Policy/Regulatory, About PWUD, Workplace, Substitution/OAT, Peer/PWLLE program involvement, Harm reduction
For PWID, intersectional experiences of stigma and other social vulnerabilities may influence their experiences navigating medical care.
Original research | 2021
About pharmacists, About PWUD, Barriers and enablers, Poverty, Illegal drugs, Stigma
Webpage | 2020
Safer supply, Advocacy
this study aimed to understand the impacts of the COVID-19 pandemic on LGBTQ2S youth at risk of, and experiencing, homelessness in the Greater Toronto Area, Ontario, Canada and surrounding areas.
Original research | 2021
About PWUD, Housing, Youth, 2SLGBTQI+
To identify implementation barriers and facilitators to the adoption and implementation of programs that provide opioid agonist treatments (OAT) with methadone and buprenorphine to treat opioid use di
Original research | 2021
Safer supply, About prescribers, Legal system/law enforcement, Substitution/OAT
Experts running safer supply programs in Ontario provide an overview of their programs; program participants share experiences
Archived webinar | 2020
Safer supply, About prescribers, About PWUD
Dr. Mark Tyndall presents about MySafe - an innovative safe supply project which uses biometric dispensing technology to provide registered users with safe supply hydromophone
Archived webinar | 2020
Overdose, Safer supply
We aimed to estimate Canadian national time trends in opioid-related mortality from 2000 to 2017 and opioid-related hospitalization and emergency department visits between 2000 and 2012.
Original research | 2021
Overdose, Mortality, Evidence base, Hospitals
Letter | 2020
Policy/Regulatory, Safer supply, Advocacy

This study sought to investigate the possible relationship between recent naturalistic psychedelic use and subsequent daily illicit opioid use among people who use drugs (PWUD).

Original research | 2022
About PWUD, Outcomes, Illegal drugs, Hallucinogens/psychedelics
Alberta Health Services is committed to providing a patient-focused, quality health system that is accessible and sustainable for all Albertans.
Policy | 2020
Clinical guidance, Policy/Regulatory, About prescribers, Illegal drugs, Hospitals
This resource provides information and recommendations to chronic pain practitioners and patients during the COVID-19 pandemic.
Guidelines | 2020
Withdrawal, Clinical guidance, Harm reduction, About prescribers, Chronic pain
The objective of this study was to qualitatively explore Philadelphia-based low-barrier, harm-reduction oriented, opioid use disorder (OUD) treatment provider perspectives about and experiences with t
Original research | 2021
About prescribers, Barriers and enablers, Substitution/OAT, Transitions in care/treatment, Digital health

To evaluate the effects of the SAMSHA exemption on methadone adherence and OUD-related outcomes.

Original research | 2021
Policy/Regulatory, About prescribers, Outcomes, Substitution/OAT, Carries/take-home doses
The aim of this article is to systematically and critically review the arguments and counterarguments about the definitions of disaster, crisis, and emergency to date
Original research | 2016
Overdose, Advocacy

Refine Your Search